Summary
Further key aspects of the report indicate that:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary.
The global Hepatitis A Vaccine market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for Hepatitis A Vaccine are the significant development of demand and improvement of COVID-19 and geo-economics.
Based on the type of product, the global Hepatitis A Vaccine market segmented into
Liver Inactivated Vaccine
Live Attenuated Vaccine
Based on the end-use, the global Hepatitis A Vaccine market classified into
Hospitals
Other Medical Institutions
Based on geography, the global Hepatitis A Vaccine market segmented into
North America [U.S., Canada, Mexico]
Europe [Germany, UK, France, Italy, Rest of Europe]
Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
South America [Brazil, Argentina, Rest of Latin America]
Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]
And the major players included in the report are
GlaxoSmithKline
Merck Sharp & Dohme Corp
SANOFI PASTEUR S.A
Norvatis
Crucell Switzerland AG(Berna+Crucell)
China Academy of Medical Sciences
Changchun Institute of Biological Products
Zhejiang Pukang
ChangSheng
Sinovac
Shanghai Zerun Biotechnology
Table of Contents
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL HEPATITIS A VACCINE INDUSTRY
2.1 Summary about Hepatitis A Vaccine Industry
2.2 Hepatitis A Vaccine Market Trends
2.2.1 Hepatitis A Vaccine Production & Consumption Trends
2.2.2 Hepatitis A Vaccine Demand Structure Trends
2.3 Hepatitis A Vaccine Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Liver Inactivated Vaccine
4.2.2 Live Attenuated Vaccine
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Hospitals
4.3.2 Other Medical Institutions
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Liver Inactivated Vaccine
5.2.2 Live Attenuated Vaccine
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Hospitals
5.3.2 Other Medical Institutions
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Liver Inactivated Vaccine
6.2.2 Live Attenuated Vaccine
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Hospitals
6.3.2 Other Medical Institutions
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Liver Inactivated Vaccine
7.2.2 Live Attenuated Vaccine
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Hospitals
7.3.2 Other Medical Institutions
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Liver Inactivated Vaccine
8.2.2 Live Attenuated Vaccine
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Hospitals
8.3.2 Other Medical Institutions
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Liver Inactivated Vaccine
9.2.2 Live Attenuated Vaccine
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Hospitals
9.3.2 Other Medical Institutions
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 GlaxoSmithKline
10.1.2 Merck Sharp & Dohme Corp
10.1.3 SANOFI PASTEUR S.A
10.1.4 Norvatis
10.1.5 Crucell Switzerland AG(Berna+Crucell)
10.1.6 China Academy of Medical Sciences
10.1.7 Changchun Institute of Biological Products
10.1.8 Zhejiang Pukang
10.1.9 ChangSheng
10.1.10 Sinovac
10.1.11 Shanghai Zerun Biotechnology
10.2 Hepatitis A Vaccine Sales Date of Major Players (2017-2020e)
10.2.1 GlaxoSmithKline
10.2.2 Merck Sharp & Dohme Corp
10.2.3 SANOFI PASTEUR S.A
10.2.4 Norvatis
10.2.5 Crucell Switzerland AG(Berna+Crucell)
10.2.6 China Academy of Medical Sciences
10.2.7 Changchun Institute of Biological Products
10.2.8 Zhejiang Pukang
10.2.9 ChangSheng
10.2.10 Sinovac
10.2.11 Shanghai Zerun Biotechnology
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT
List of Table
Table Hepatitis A Vaccine Product Type Overview
Table Hepatitis A Vaccine Product Type Market Share List
Table Hepatitis A Vaccine Product Type of Major Players
Table Brief Introduction of GlaxoSmithKline
Table Brief Introduction of Merck Sharp & Dohme Corp
Table Brief Introduction of SANOFI PASTEUR S.A
Table Brief Introduction of Norvatis
Table Brief Introduction of Crucell Switzerland AG(Berna+Crucell)
Table Brief Introduction of China Academy of Medical Sciences
Table Brief Introduction of Changchun Institute of Biological Products
Table Brief Introduction of Zhejiang Pukang
Table Brief Introduction of ChangSheng
Table Brief Introduction of Sinovac
Table Brief Introduction of Shanghai Zerun Biotechnology
Table Products & Services of GlaxoSmithKline
Table Products & Services of Merck Sharp & Dohme Corp
Table Products & Services of SANOFI PASTEUR S.A
Table Products & Services of Norvatis
Table Products & Services of Crucell Switzerland AG(Berna+Crucell)
Table Products & Services of China Academy of Medical Sciences
Table Products & Services of Changchun Institute of Biological Products
Table Products & Services of Zhejiang Pukang
Table Products & Services of ChangSheng
Table Products & Services of Sinovac
Table Products & Services of Shanghai Zerun Biotechnology
Table Market Distribution of Major Players
Table Global Major Players Sales Revenue (Million USD) 2017-2020e
Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
Table Global Hepatitis A Vaccine Market Forecast (Million USD) by Region 2021f-2026f
Table Global Hepatitis A Vaccine Market Forecast (Million USD) Share by Region 2021f-2026f
Table Global Hepatitis A Vaccine Market Forecast (Million USD) by Demand 2021f-2026f
Table Global Hepatitis A Vaccine Market Forecast (Million USD) Share by Demand 2021f-2026f
List of Figure
Figure Global Hepatitis A Vaccine Market Size under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Hepatitis A Vaccine Market by Region under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Hepatitis A Vaccine Market by Product Type under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Hepatitis A Vaccine Market by Demand under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Hepatitis A Vaccine Production by Region under the Impact of COVID-19, 2021-2026 (USD Million)
Figure Global Hepatitis A Vaccine Consumption by Region under the Impact of COVID-19, 2021-2026 (USD Million)
Figure Global Hepatitis A Vaccine Consumption by Type under the Impact of COVID-19, 2021-2026 (USD Million)
Figure North America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Asia-Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure South America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Liver Inactivated Vaccine Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Live Attenuated Vaccine Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Hospitals Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Other Medical Institutions Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure U.S. Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Canada Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Mexico Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Liver Inactivated Vaccine Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Live Attenuated Vaccine Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Hospitals Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Other Medical Institutions Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Germany Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure UK Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure France Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Italy Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Liver Inactivated Vaccine Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Live Attenuated Vaccine Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Hospitals Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Other Medical Institutions Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure China Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure India Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Japan Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure South Korea Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Southeast Asia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Australia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Asia Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Liver Inactivated Vaccine Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Live Attenuated Vaccine Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Hospitals Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Other Medical Institutions Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Brazil Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Argentina Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Latin America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Liver Inactivated Vaccine Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Live Attenuated Vaccine Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Hospitals Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Other Medical Institutions Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure GCC Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure North Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure South Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Liver Inactivated Vaccine Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Live Attenuated Vaccine Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Hospitals Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Other Medical Institutions Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Hepatitis A Vaccine Sales Revenue (Million USD) of GlaxoSmithKline 2017-2020e
Figure Hepatitis A Vaccine Sales Revenue (Million USD) of Merck Sharp & Dohme Corp 2017-2020e
Figure Hepatitis A Vaccine Sales Revenue (Million USD) of SANOFI PASTEUR S.A 2017-2020e
Figure Hepatitis A Vaccine Sales Revenue (Million USD) of Norvatis 2017-2020e
Figure Hepatitis A Vaccine Sales Revenue (Million USD) of Crucell Switzerland AG(Berna+Crucell) 2017-2020e
Figure Hepatitis A Vaccine Sales Revenue (Million USD) of China Academy of Medical Sciences 2017-2020e
Figure Hepatitis A Vaccine Sales Revenue (Million USD) of Changchun Institute of Biological Products 2017-2020e
Figure Hepatitis A Vaccine Sales Revenue (Million USD) of Zhejiang Pukang 2017-2020e
Figure Hepatitis A Vaccine Sales Revenue (Million USD) of ChangSheng 2017-2020e
Figure Hepatitis A Vaccine Sales Revenue (Million USD) of Sinovac 2017-2020e
Figure Hepatitis A Vaccine Sales Revenue (Million USD) of Shanghai Zerun Biotechnology 2017-2020e
Executive Summary
Azoth Analytics has released a research report titled "Global Cold Chain Equipment Market (2024 Edition)" which provides a complete analysis of the Global Cold Chain Equipment market in terms of market segmentation By Equipment Type (Refrigerators, Deep Freezers & Reef...
Overview of the Global Vaccine Supply Chain Solutions Market:
The report discusses everything a marketer requires before investing in the global Vaccine Supply Chain Solutions Market during the forecast period 2023-...
Overview of the Global Digital Vaccine Tracking System Market:
The report discusses everything a marketer requires before investing in the global Digital Vaccine Tracking System Market during the forecast period 202...
Asia Pacific preventive vaccines market will grow by 7.9% annually with a total addressable market cap of $217.46 billion over 2023-2032, driven by the rising prevalence of several infectious diseases, rising R&D investment and technological advancement in vaccination technologies, rising need for p...
Europe preventive vaccines market was valued at $18.02 billion in 2022 and will grow by 5.1% annually over 2022-2032, driven by the rising prevalence of several infectious diseases, rising R&D investment and technological advancement in vaccination technologies, rising need for preventive vaccines s...
North America preventive vaccines market is projected to grow by 6.3% annually in the forecast period and reach $46.90 billion by 2032, driven by the rising prevalence of several infectious diseases, rising R&D investment and technological advancement in vaccination technologies, rising need for pre...
Global preventive vaccines market will reach $120.07 billion by 2032, growing by 6.4% annually over 2022-2032, driven by the rising prevalence of several infectious diseases, rising R&D investment and technological advancement in vaccination technologies, rising need for preventive vaccines such as ...
The global Whole Cell Cholera Vaccine market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players i...
The global Viral Vaccine Media market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this ...
The global Vero Cell Rabies Vaccine market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in ...